reports
Marrone Bio Innovations, Inc. Shareholders Approve Merger Agreement wi...
Marrone Bio Innovations, Inc. Shareholders Approve Merger Agreement with Bioceres Crop Solutions Corp. RALEIGH, N.C., July 11, 2022 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII) (MBI) announced that during a special shareholder meeting held on July 8, 2022, its shareholders approved a proposal to adopt the previously announced Agreement and Plan of Merger (Merger Agreement), dated as of March 16, 2022, by and among Bioceres Crop Solutions Corp. (BIOX), BCS Merger Sub, Inc., and MBI, pursuant to which MBI will be acquired by BIOX. At the special meeting, MBI’s stockholde...
Marrone Bio Innovations, Inc. Reports First-Quarter 2022 Financial Res...
Marrone Bio Innovations, Inc. Reports First-Quarter 2022 Financial Results RALEIGH, N.C., May 11, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: MBII), an international leader in sustainable bioprotection and plant health solutions, has provided its financial results for the first quarter ended March 31, 2022. Key results include: Higher sales of row crop products in the first quarter were somewhat offset by lower sales into specialty crop markets, which were affected by adverse weather conditions. Based on the strength of current orders, revenues in the first half are expected to increase in the ...
Marrone Bio Innovations to Report First Quarter 2022 Results on Wednes...
Marrone Bio Innovations to Report First Quarter 2022 Results on Wednesday, May 11 at 4:30 p.m. Eastern Time RALEIGH, N.C., April 27, 2022 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII), an international leader in providing growers with sustainable bioprotection and plant health solutions to support global agricultural needs, will release financial results for the first quarter ended March 31, 2022, after market close on Wednesday, May 11, 2022. Management will host an investor conference call at 4:30 p.m. ET to discuss Marrone Bio Innovations’ first quarter financial re...
Marrone Bio Innovations, Inc. Reports Fourth-Quarter and Full-Year 202...
Marrone Bio Innovations, Inc. Reports Fourth-Quarter and Full-Year 2021 Financial Results RALEIGH, N.C., March 28, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: MBII), an international leader in sustainable bioprotection and plant health solutions, has provided its financial results for the fourth quarter and full year ended December 31, 2021. Key results include: Full year revenues rose 15.5%, with a 40.2% increase in the fourth quarter.Gross profit grew 19.1% and 31.5% for the full year and fourth quarter, respectively, with margins exceeding 59% in both periods.For the full year, net loss was ...
Marrone Bio Expands Biological Seed Treatment Collaboration for Row Cr...
Marrone Bio Expands Biological Seed Treatment Collaboration for Row Crops Company poised for continued growth in a $6+ billion market¹ RALEIGH, N.C., March 24, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: MBII), has signed an agreement with Corteva Agriscience (NYSE: CTVA) that expands the opportunity for MBI technologies to be used on seeds sold by Corteva for row crops globally. Marrone Bio currently provides seed treatment solutions to Corteva for use throughout Europe. MBI introduced biological seed treatments as a sustainable alternative to control yield-robbing pests in the United States i...
Bioceres Crop Solutions and Marrone Bio Announce Merger Agreement
Bioceres Crop Solutions and Marrone Bio Announce Merger Agreement Combined company creates global leader in sustainable agricultural solutions Bioceres obtains commitment for up to $45 million loan facility and conversion of existing convertible notes into shares and new term loan facility ROSARIO, Argentina and RALEIGH, N.C., March 16, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: BIOX) (Bioceres) and Marrone Bio Innovations, Inc. (NASDAQ: MBII) (MBI) announced today that they have entered into a definitive agreement to combine the companies in an all-stock transaction. Under the terms of the tra...
Marrone Bio Innovations to Report Fourth Quarter and Full Year 2021 Re...
Marrone Bio Innovations to Report Fourth Quarter and Full Year 2021 Results on Monday, March 28 at 4:30 p.m. Eastern Time RALEIGH, N.C., March 08, 2022 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII), an international leader in providing growers with sustainable bioprotection and plant health solutions to support global agricultural needs, will release financial results for the fourth quarter and full year ended December 31, 2021, after market close on Monday, March 28, 2022. Management will host an investor conference call at 4:30 p.m. ET to discuss Marrone Bio Innovati...
Marrone Bio Announces CFO Transition
Marrone Bio Announces CFO Transition RALEIGH, N.C., Feb. 22, 2022 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII), an international leader in sustainable bioprotection and plant health solutions, announced today a transition of its Chief Financial Officer role. Current CFO Sue Cheung has chosen to resign for personal reasons, effective March 9, 2022. LaDon Johnson, a director with CFO Systems, has been appointed interim CFO on a consulting basis while the company begins a national search for a permanent CFO. “We appreciate Sue’s contributions to Marrone Bio over the pa...
Marrone Bio and Corteva Agriscience Announce New Distribution Contract
Marrone Bio and Corteva Agriscience Announce New Distribution Contract The companies build on existing seed treatment partnership to offer novel foliar bionutrient GENEVA and RALEIGH, N.C., Feb. 15, 2022 (GLOBE NEWSWIRE) -- Growers in Europe will have access to a novel, sustainable option for enhancing plant health and crop quality through a new agreement between Pro Farm Technologies, a subsidiary of Marrone Bio Innovations, Inc. (MBI) (NASDAQ: MBII) and Corteva Agriscience (NYSE: CTVA). Under the agreement, Corteva will be the exclusive European distributor for Kinsidro® Grow, a novel...
Marrone Bio Innovations Issues Shareholder Letter
Marrone Bio Innovations Issues Shareholder Letter Announces Preliminary Fourth Quarter and Fiscal Year 2021 Financial Results RALEIGH, N.C., Jan. 18, 2022 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII), an international leader in providing growers with sustainable bioprotection and plant health solutions to support global agricultural needs, today released an update letter to shareholders from Chief Executive Officer Kevin Helash announcing preliminary financial results for the fourth quarter and fiscal year ended December 31, 2021. Dear Shareholders, As we begin...
Marrone Bio’s Inventory Line of Credit Increased to Support Sales and ...
Marrone Bio’s Inventory Line of Credit Increased to Support Sales and Manufacturing Growth RALEIGH, N.C., Jan. 06, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: MBII) has expanded its existing inventory line of credit to support the company’s expectations for growth in sales and manufacturing capacity. Under an amended agreement with LSQ Funding Group, L.C., the company can access a maximum of $4.5 million to finance inventory needs, up from $3 million under a prior agreement. “The increase in the line of credit for inventory provides us with greater flexibility to support the company’s commerc...
Marrone Bio Relocates Corporate Headquarters to Raleigh, North Carolin...
Marrone Bio Relocates Corporate Headquarters to Raleigh, North Carolina Supports Growth Plans in European and Latin American markets RALEIGH, N.C., Jan. 06, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: MBII), an international leader in sustainable bioprotection and plant health solutions, today announced it has relocated its corporate headquarters from Davis, California, to Raleigh, North Carolina, to support the company’s growing presence in markets outside the United States. The move predominantly affects corporate executive positions. Davis will continue to be the hub for the company’s researc...
Marrone Bio Warrant Holders Exercise Final Tranche, Eliminating Warran...
Marrone Bio Warrant Holders Exercise Final Tranche, Eliminating Warrant Overhang DAVIS, Calif., Dec. 16, 2021 (GLOBE NEWSWIRE) -- During November and December 2021, certain warrant holders in (NASDAQ: MBII) completed the exercise of the fifth and final tranche of warrants, generating a total of $3.5 million in cash during the fourth quarter of 2021 and increasing the company’s outstanding shares by 4.7 million. With these exercises, and the December 15, 2021, expiration of the substantial majority of the company’s other unexercised warrants, the company’s material warrant overhang has be...
Marrone Bio Optimizes Bioherbicide with New Bacteria Strains, Accelera...
Marrone Bio Optimizes Bioherbicide with New Bacteria Strains, Accelerates Product Development to Enter $27 Billion Herbicide Market¹ DAVIS, Calif., Dec. 16, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: MBII), has acquired exclusive rights to high-performing strains of Streptomyces acidiscabies, allowing for the accelerated commercialization of a new, second-generation bioherbicide, MBI-006. The addition of these strains, developed by and licensed from Novozymes, a world leader in industrial enzymes and microorganisms, will optimize MBI-006’s use rate, lower the cost of production, and enhance perfo...
Marrone Bio’s Next-Generation Product for Environmentally Sustainable ...
Marrone Bio’s Next-Generation Product for Environmentally Sustainable Pest Control Demonstrates Substantial Yield Gains in 2021 Field Trials Estimated peak potential revenue for MBI-306 and its variants is $100 million DAVIS, Calif., Dec. 08, 2021 (GLOBE NEWSWIRE) -- Field trials in 2021 for Marrone Bio Innovations’ (NASDAQ: MBII) next-generation product for environmentally sustainable control of yield-robbing pests in corn and soybeans demonstrated excellent efficacy with substantial yield gains at reduced application rates. “MBI-306 continues to demonstrate the benefits that farmer...
Marrone Bio Achieves Excellent Climate Impact Score for Venerate® XC B...
Marrone Bio Achieves Excellent Climate Impact Score for Venerate® XC Bioinsecticide DAVIS, Calif., Nov. 17, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: MBII) (MBI), an international leader in sustainable bioprotection and plant health solutions published today their independent climate impact product assessment on Venerate® XC Bioinsecticide, scoring a 8.6 out of 10. The analysis evaluated the life-cycle inputs and impacts of Venerate XC per acre on the following: soil, aquatic and human toxicity, ecosystem impact, harmful materials, greenhouse gas (GHG) emissions and carbon return on investment (...
Marrone Bio Innovations, Inc. Reports Third-Quarter 2021 Financial Res...
Marrone Bio Innovations, Inc. Reports Third-Quarter 2021 Financial Results DAVIS, Calif., Nov. 10, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: MBII), an international leader in sustainable bioprotection and plant health solutions, has provided its financial results for the third quarter ended September 30, 2021. Key results include: Strategic focus on global expansion in the major row crops was a key contributor to the 12% revenue growth for the third quarter. Sales of biological fungicides also increased during the period.Stronger mix of higher margin seed treatments led to gross profit of 61.4%...
Marrone Bio Innovations Receives Nasdaq Notice Regarding Failure to Sa...
Marrone Bio Innovations Receives Nasdaq Notice Regarding Failure to Satisfy a Continued Listing Rule DAVIS, Calif., Nov. 08, 2021 (GLOBE NEWSWIRE) -- (Nasdaq: MBII) today announced that it has received a letter from the Listing Qualifications Department of the Nasdaq Capital Market notifying the company of its noncompliance with Nasdaq Listing Rule 5550(a)(2) as a result of the company’s closing bid price being below $1.00 per share for 30 consecutive days. Under Nasdaq Listing Rules, the company has 180 calendar days from the date of the notification to regain compliance with Nasdaq Li...
Marrone Bio Submits Regulatory Packages for Nematicides/Insecticides i...
Marrone Bio Submits Regulatory Packages for Nematicides/Insecticides in United States and Brazil Peak potential revenue for both products is estimated in excess of $100 million DAVIS, Calif., Nov. 01, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: MBII), an international leader in sustainable bioprotection and plant health solutions, has submitted the regulatory packages for MBI-306 to the U.S. Environmental Protection Agency (EPA) and for MBI-206 to all three Brazilian regulatory authorities – the National Health Surveillance Agency (ANVISA), the Ministry of Agriculture (MAPA) and the Institute of...
Marrone Bio Innovations to Report Third Quarter 2021 Results on Wednes...
Marrone Bio Innovations to Report Third Quarter 2021 Results on Wednesday, November 10 at 4:30 p.m. Eastern Time DAVIS, Calif., Oct. 27, 2021 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII), an international leader in providing growers with sustainable bioprotection and plant health solutions to support global agricultural needs, will release financial results for the third quarter ended September 30, 2021, after market close on Wednesday, November 10, 2021 at 4:30 p.m. Eastern time. Management will host an investor conference call at 4:30 p.m. ET (1:30 p.m. PT) on Novem...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.